...
首页> 外文期刊>Journal of Medicinal Chemistry >'Lead hopping'. Validation of topomer similarity as a superior predictor of similar biological activities
【24h】

'Lead hopping'. Validation of topomer similarity as a superior predictor of similar biological activities

机译:“跳铅”。验证拓扑异构体作为相似生物活性的优良预测指标

获取原文
获取原文并翻译 | 示例

摘要

Two extensive studies quantifying the ability of topomer shape similarity to forecast a variety of biological similarities are described. In a prospective trial of "lead hopping", using topomer similarity for virtual screening and queries from the patent literature, biological assays of 308 selected compounds (representing 0.03% of those available, per assay type) yielded 11 successful "lead hops" in the 13 assays attempted. The hit rate averaged over all assays was 39% ("activity" defined as inhibition greater than or equal to 20% at 10 muM), significantly greater than an unexpectedly high negative control hit rate of 15%. The average "Tanimoto 2D fingerprint similarity" between query and "lead hop" structures (0.36) was little more than the Tanimoto similarity between random drug-like structures. Topomer shape and Tammoto 2D fingerprint similarities were also compared retrospectively, in their tendencies to concentrate together potential and actual drugs reported to belong to the same "activity class", for twenty classes. Among the most similar 3% of structures (corresponding to "greater than or equal to 0.85 Tanimoto" for these structures), an average of 62% of the topomer similar selection possessed a near neighbor belonging to the same activity class, roughly a one-third superiority over the "Tanimoto greater than or equal to 0.85" selection containing 48% actives in avoiding false positives. Conversely, the least similar 75% of structures contained 0.3% actives for topomer similarity vs 1.0% actives for Tanimoto 2D fingerprint similarity, a 3-fold superiority for topomers in avoiding false negatives.
机译:描述了两项广泛的研究,量化了拓扑异构体形状相似性预测各种生物学相似性的能力。在一项针对“铅跳跃”的前瞻性试验中,使用拓扑异构体相似性进行虚拟筛选和专利文献的查询,对308种选定化合物的生物测定(每种测定类型占可用化合物的0.03%)进行了11次成功的“铅跳跃”分析。尝试了13种测定。所有测定的平均命中率是39%(“活性”定义为在10μM时抑制大于或等于20%),大大高于意外高的15%阴性对照命中率。查询和“前导跳”结构之间的平均“ Tanimoto 2D指纹相似性”(0.36)仅比随机药物样结构之间的Tanimoto相似性高。还回顾了拓扑异构体形状和Tammoto 2D指纹相似性的趋势,将它们集中于报告的属于同一“活性类别”的二十种潜在药物和实际药物的倾向。在最相似的3%结构中(相当于这些结构的“大于或等于0.85 Tanimoto”),平均约62%的类似选择拓扑异构体拥有属于同一活性类别的近邻,大约是一个相对于“ Tanimoto大于或等于0.85”选择的第三项优势在于避免误报的48%活​​性。相反,最不相似的75%结构包含对拓扑异构体相似性为0.3%的活性物,而对于Tanimoto 2D指纹相似性为1.0%活性物,对拓扑异构体而言,在避免假阴性方面具有3倍的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号